Post-translational modification of SOX family proteins: Key biochemical targets in cancer? (2020)
Attributed to:
Engineering novel synthetic factors to reprogram cell identity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.semcancer.2019.09.009
PubMed Identifier: 31539559
Publication URI: http://europepmc.org/abstract/MED/31539559
Type: Journal Article/Review
Volume: 67
Parent Publication: Seminars in cancer biology
Issue: Pt 1
ISSN: 1044-579X